AMO’s Complete MoisturePlus
This article was originally published in The Gray Sheet
Executive Summary
Advanced Medical Optics' voluntary recall in May of the multipurpose contact lens solution is classified as Class I by FDA, meaning the product poses a "reasonable probability" of serious adverse health consequences, namely the rare eye infection Acanthamoeba keratitis. The firm is rolling out a replacement Complete multipurpose solution this month (1"The Gray Sheet" July 30, 2007, In Brief)...
You may also be interested in...
AMO lens solution re-entry
Firm will reintroduce a Complete brand of multipurpose lens solution in the United Sates in early August, with wide availability expected by September, AMO says July 23. The company will phase in the product globally throughout the fall. AMO withdrew its Complete MoisturePlus multipurpose solution from the market in May due to links to increased incidence of Acanthamoeba keratitis eye infections among users (1"The Gray Sheet" July 2, 2007, p. 12)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.